| P50 | author | Saverio Minucci | Q87085503 |
| P2093 | author name string | Pier Giuseppe Pelicci | |
| | Sara Gandini | |
| | Luca Mazzarella | |
| | Federica Corso | |
| | Federica Bellerba | |
| | Bruno Achutti Duso | |
| | Giulia Tini | |
| P2860 | cites work | Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements. | Q52690719 |
| | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Q87412594 |
| | A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | Q88370045 |
| | Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both | Q88454216 |
| | The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? | Q89840059 |
| | Potential association between COVID-19 mortality and health-care resource availability | Q89936449 |
| | A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 | Q90750837 |
| | Optimizing the Trade-off Between Learning and Doing in a Pandemic | Q90750880 |
| | Master protocols in immuno-oncology: do novel drugs deserve novel designs? | Q90833383 |
| | Global coalition to accelerate COVID-19 clinical research in resource-limited settings | Q91565190 |
| | Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score | Q91758697 |
| | Compassionate Use of Remdesivir for Patients with Severe Covid-19 | Q91807066 |
| | COVID-19 and risks to the supply and quality of tests, drugs, and vaccines | Q91826156 |
| | Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review | Q91855760 |
| | Master protocols in clinical trials: a universal Swiss Army knife? | Q92510789 |
| | Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial | Q94771078 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | COVID-19 | Q84263196 |
| P304 | page(s) | 367 | |
| P577 | publication date | 2020-06-29 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness | |
| P478 | volume | 7 | |